CMT with Pyramidal Features
Neurol 60:696-699, Vucic,S.,et al, 2003
Case Report: Recurrent Temporalis Muscle Swelling and Headache
Neurol 60:724-725, McGuigan,C.,et al, 2003
Early Major Ischemic Changes on Computed Tomography Should Preclude Use of Tissue Plaminogen Activator
Stroke 34:820-821,822, von Kummer,R., 2003
Early Major Ischemic Changes on Computed Tomography Should Not Preclude Use of Tissue Plasminogen Activator
Stroke 34:821-822,822, Lyden,P.,et al, 2003
[123I]b-CIT SPECT is a Useful Method for Monitoring Dopaminergic Degeneration in Early Stage Parkinson's Disease
JNNP 74:294-298,287, Winogrodzka,A.,et al, 2003
Development in Pain and Neurologic Complaints After Whiplash
Neurol 60:743-761,733, Kasch,H.,et al, 2003
Ten Most Commonly Asked Questions About the Psychiatric Aspects of Parkinson's Disease
The Neurologist 9:50-56, Reich,S.G. & Marsh,L., 2003
Neuronal Loss Is Greater in the Locus Coeruleus Than Nucleus Basalis and Substantia Nigra in Alzheimer and Parkinson Diseases
Arch Neurol 60:337-341, 320, Zarow,C.,et al, 2003
Ipsilateral Truncal Sensory Deficit in a Patient with Ophthalmic Zoster Sine Herpete
Neurol 60:1049-1050, Yamada,S.,et al, 2003
Clinical Features and Natural Histry of Progressive Supranuclear Palsy, A Clinical Cohort Study
Neurol 60:910-916, Nath,W.,et al, 2003
Diffusion-Weighted Imaging Discriminates Progressive Supranuclear Palsy from PD, But Not From the Parkinson Variant of Multiple System Atrophy
Neurol 60:922-927, Seppi,K.,et al, 2003
Stem Cells and Neurological Disease
JNNP 74:553-557, Barker,R.A.,et al, 2003
Randomized Trial of Pallidotomy Versus Medical Therapy for Parkinson's Disease
Ann Neurol 53:558-569, Vitek,J.L.,et al, 2003
The 12 Year Prognosis of Unilateral Functional Weakness and Sensory Disturbance
JNNP 74:591-596,557, Stone,J.,et al, 2003
Reappraisal of Early CT signs to Predict the Arterial Occlusion Site in Acute Embolic Stroke
JNNP 74:649-653, Koga,M.,et al, 2003
Weight Loss in Parkinson's Disease
Ann Neurol 53:676-679, Chen,H.,et al, 2003
Safety and Feasibility of a CT Protocol for Acute Stroke: Combined CT, CT Angiography, and CT Perfusion Imaging in 53 Consecutive Patients
AJNR 24:688-690, Smith,W.S.,et al, 2003
Neurologic Complications of Anthrax
Arch Neurol 60:483-488, Meyer,M.A., 2003
Parkinson Disease With Old-Age Onset
Arch Neurol 60:529-533, Diederich,N.J.,et al, 2003
Identifying the Pattern of Olfactory Deficits in Parkinson Disease Using the Brief Smell Identification Test
Arch Neurol 60:545-549, Double,K.L.,et al, 2003
Clinical Features of Headache at Altitude
Neurol 60:1167-1171, Silber,E.,et al, 2003
Detection of Diffusion-Weighted MRI Abnormalities in Patients with Transient Ischemic Attack
Stroke 34:932-937, Crisostomo,R.A.,et al, 2003
Emergency Calls in Acute Stroke
Stroke 34:1005-1009, Handschu,R.,et al, 2003
Alzheimer's Disease and Parkinson's Disease
NEJM 348:1356-1364, Nussbaum,R.L. &Ellis,C.E., 2003
Wrong-way Eyes with Thalamic Hemorrhage
Neurol 60:1524, Messe,S.R. &Cucchiara,B.L., 2003
Pain in the Neck
Lancet 361:1700, Nicholls,S.,et al, 2003
T1 Hyperintensity in the Pulvinar: Key Imaging Feature for Diagnosis of Fabry Disease
AJNR 24:916-921, Takanashi,J.,et al, 2003
Subdural Haematoma: A Potentially Serious Consequence of Spontaneous Intracranial Hypotension
JNNP 74:752-755, de Noronha,R.J.,et al, 2003
Mental Illness in New Neurological Patients
JNNP 74:817-819, Fink,P.,et al, 2003
Acupuncture in Clinical Neurology
The Neurologist 9:137-148, Rabinstein,A.A. &Shulman,L.M., 2003
Headache and Confusion: the Dangers of a Raw Snail Supper
Lancet 361:1866, Chau,T.T.H.,et al, 2003
Staging of Brain Pathology Related to Sporadic Parkinsons Disease
Neurobiol Aging 24:197-211, Braak,H.,et al, 2003
Encephalitis lethargica syndrome:20 new cases and evidence of basal ganglia autoimmunity
Brain 127, 21-33, Dale, R.C., et al, 2003
Isolated Deep Cerebral Venous Thrombosis Diagnosed on CT and MR Imaging. A Case Study and Literature Review.
JBR-BTR 86:257-261, Crombe,D.,et al, 2003
Unilateral Brachial Plexopathy Associated with West Nile Virus Meningoencephalitis
CID 36:162-1630, Almhanna,K.,et al, 2003
Mutations in the Molybdenum Cofactor Biosynthetic Genes MOCS1, MOCS2, and GEPH
Hum Mutat 21:569-576, Reiss,J. &Johnson,J.L., 2003
Occipital Seizures Presenting with Bilateral Visual Loss
Neurol India d51:115-116, Hadjikoutis, S. & Sawhney, M., 2003
Mycoplasma Pneumoniae Encephalitis in Childhood
J Microbiol Immunol Infect 35:173-178, Lin,W.-C., et al, 2002
A Practical Approach to the Diagnosis and Management of MELAS: Case Report and Review
The Neurologist 8:302-312, Thambisetty,M.,et al, 2002
Ossification of the Cervical Posterior Longitudinal Ligament: A Review
Neurosurg Focus 13:1-10, Epstein,N., 2002
Mitochondrial Therapy for Parkinson Disease
Arch Neurol 59:1523, Rosenberg,R.N., 2002
Potentially Reversible Conditions in 1000 Consecutive Memory Clinic Patients
JNNP 73:390-394, Hejl,A.,et al, 2002
Intakes of Vitamins E and C, Carotenoids, Vitamin Supplements, and PD Risk
Neurol 59:1161-1169, Zhang,S.M.,et al, 2002
T2-weighted MRI Differentiates Multiple System Atrophy from Parkinson's Disease
Neurol 59;1265-1267, Kraft,E.,et al, 2002
Comparison of CT and CT Angiography Source Images With Diffusion-Weighted Imaging in Patients With Acute Stroke Within 6 Hours After Onset
Stroke 33:2426-2432, Schramm,P.,et al, 2002
Brain Calcifications in Systemic Sclerosis
Arch Neurol 59:1642-1643, Gusbi,O. &Bernardini,G.L., 2002
Etiology, During, and Prognosis of Transient Ischemic Attacks
Arch Neurol 59:1584-1588, Weimar,C.,et al, 2002
Therapies for Movement Disorders
Arch Neurol 59:699-702, Goetz,C.G &Hinson,V.K., 2002
Treatment Interventions for Parkinson's Disease: An Evidence Based Assessment
Lancet 359:1589-1598, Rascol,O.,et al, 2002
Impact of Sustained Deprenyl (Selegiline) in Levodopa-Treated Parkinson's Disease: A Randomized Placebo-Controlled Extension of the Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism Trial
Ann Nuerol 51:604-612, Shoulson,I.,et al, 2002